Phase I maximum tolerated dose study of RAD 1901 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Elacestrant (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Radius Health Inc.
- 15 Jul 2015 According to a Radius Health media release, final results of this study are expected in the third quarter of 2015.
- 15 Jul 2015 Status changed from recruiting to completed according to a Radius Health media release.
- 11 Dec 2014 Trial design presented at the 37th Annual San Antonio Breast Cancer Symposium.